Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bioequivalence Study of Cyclobenzaprine Hydrochloride 10 mg Tablets, USP Under Fasting Conditions

This study has been completed.
Information provided by:
Ranbaxy Inc. Identifier:
First received: October 22, 2008
Last updated: NA
Last verified: October 2008
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2006
  Primary Completion Date: September 2006 (Final data collection date for primary outcome measure)